The Selection of Essential Drugs, WHO Techn. Rep. Ser. No. 615, 1977.
3.
OTC Drugs Face Stiff Regulations in Industrialized Nations, Int. Drug Regul. Monit. No. 60:11–14, 1978.
4.
Japan, Canada, USA Take Lead in Medical Device Regulation, Int. Drug Regul. Monit. No. 46:1–14, 1977.
5.
StanfordJ. W.: “The United States Program for the Management, Development, Approval and Review of National and International Standards.” Read before the Association for the Advancement of Medical Instrumentation (AAMI) — Conference on Voluntary and Regulatory Standards for Medical Devices, June 1, 1978.
6.
Australia Issues New Drug and Device GMPs, Int. Drug Regul. Monit. No. 57:1–14, 1978.
7.
Brazil Enacts Comprehensive Drug, Device and Cosmetic Law, Int. Drug Regul. Monit. No. 53:1–14, 1977.
8.
France Makes Drug Regulations Match International Guidelines, Int. Drug Regul. Monit. No. 60:1–11, 1978.
9.
Italy Applies Drug Criteria to Cosmetics and Devices, Int. Drug Regul. Monit. No. 51:6–7, 1977.
10.
Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, Pharm. Adm. Jpn.67–69, September 1977.
11.
IEC/Geneva Releases New Standard for Medical Electrical Equipment, Int. Drug Regul. Monit. No. 57:14–17, 1978.